A prospective study of the effectiveness of mesenchymal stem cell therapy for lymphedema

A prospective study of the effectiveness of mesenchymal stem cell therapy for lymphedema - Study of MSC for lymphedema

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000032564

Enrollment

Registered

2018-05-14

Start date

2018-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower limb lymphedema

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients of Unilateral lower limb lymphedema with histerectomy and pelvic lymph node dissection due to cervical and/or uterine cancerwithout radiation therapy.

Exclusion criteria

Exclusion criteria: Patients with active cancer, deep vein thronbosis and/or lymphedema morphologically classified into hyperplasia.

Design outcomes

Primary

Measure	Time frame
Immediate pre-intervantion and 1, 3, 6 months post intervention volume of edema Visual analogue scale (VAS) of pain Skin stiffness Adverse event:Clavien-dindo classification	—

Countries

Japan

Contacts

Public ContactKeita Inoue

Avenue Cell Clinic Avenue Cell Clinic

kinoue-tky@umin.ac.jp0120-382-300

Outcome results